Clinical Trial

A Clinical Registry to Demonstrate the Safety and Performance of Teleflex Vascular Access Devices

Study acronym: VADER
Recruiting
View on ClinicalTrials.gov →
Summary
The general objective of Teleflex's Vascular Access Device Registry (VADER) is to provide high-quality Level 3 (or better) data on the performance, safety and clinical benefits of Teleflex's vascular access devices when used in a real-world setting
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-09-16.
Status change: Not Yet Recruiting → Recruiting 2025-08-01
Trial Details
NCT Number NCT06604039
Lead Sponsor Teleflex
Conditions Vascular Access Device
Enrollment 2,500 participants
Start Date 2024-12-08
Primary Completion 2034-12-07 (estimated)
Study Completion 2034-12-07 (estimated)
Updated on ClinicalTrials.gov 2026-08-11